SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
TGTX
--
0.00%
--
Biotech Bonanza - Second Half Outlook
Seeking Alpha · 5d ago
Evercore ISI resumes best small/mid-cap ideas with 19 new names
seekingalpha · 07/21 03:49
TG Therapeutics (TGTX) Moves to Buy: Rationale Behind the Upgrade
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks · 07/20 16:00
Are You Looking for a Top Momentum Pick? Why TG Therapeutics (TGTX) is a Great Choice
Does TG Therapeutics (TGTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks · 07/20 16:00
Did Hedge Funds Make The Right Call On TG Therapeutics Inc (TGTX) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter
Insider Monkey · 07/13 14:23
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 07/10 11:25
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8)
Benzinga · 07/09 12:09
TG Therapeutics Announces Publication in Blood Advances Describing Unique Immunomodulatory Effects on CLL T cells by Umbralisib
GlobeNewswire · 07/08 12:00
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7)
Benzinga · 07/08 11:31
TG Therapeutics Highlights Publication Of Data In Blood Advances Journal
NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) today announced the publication of preclinical data describing the unique immunomodulatory effects of umbralisib, the Company’s
Benzinga · 07/08 11:04
TG Therapeutics Highlights Presentation Of Preclinical Data For TG-1701 BTK Inhibitor At AACR Meeting
TG Therapeutics, Inc. (NASDAQ:TGTX), today announced preclinical data presentation for TG-1701, the Company’s highly selective, BTK inhibitor, at the 2020 American Association for Cancer Research (AACR) annual
Benzinga · 06/22 13:09
TG Therapeutics Announces Preclinical Data Presentation at the 2020 American Association for Cancer Research Annual Meeting
TG Therapeutics, Inc. (TGTX), today announced preclinical data presentation for TG-1701, the Company’s highly selective, BTK inhibitor, at the 2020 American Association for Cancer Research (AACR) annual meeting, being held virtually. Importantly, we are pleas
GlobeNewswire · 06/22 13:00
bluebird On The Go, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 06/18 01:02
TG Therapeutics Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma or Follicular Lymphoma
GlobeNewswire · 06/17 12:00
TG Therapeutics finishes U.S. application for umbralisib for certain B-cell blood cancers
Seeking Alpha - Article · 06/17 11:18
TG Therapeutics Completes Rolling Submission Of New Drug Application To FDA For Umbralisib As A Treatment For Patients With Previously Treated Marginal Zone Lymphoma Or Follicular Lymphoma
NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), a biopharmaceutical company developing medicines for patients with B-cell mediated diseases, today announced the completion of the
Benzinga · 06/17 11:02
TG Therapeutics to Present at the Raymond James 2020 Human Health Innovation Conference
GlobeNewswire · 06/16 12:00
TG Therapeutics: Assessing The Commercialization Case
Seeking Alpha - Article · 06/15 15:48
TG Therapeutics' TG-1701 shows encouraging action in hematologic malignancies
Seeking Alpha - Article · 06/12 12:49
TG Therapeutics Highlights Data Presentations For European Hematology Association Meeting
TG Therapeutics, Inc. (NASDAQ:TGTX), today announced data presentations at the 25th European Hematology Association (EHA) annual congress including data from a Phase 1 study evaluating TG-1701, the Company’s once
Benzinga · 06/12 11:02